Treatment of Viral Eye Infection
For suspected viral conjunctivitis without corneal involvement (adenoviral), supportive care with cold compresses and artificial tears is the primary approach, as most cases are self-limited; however, for herpes simplex virus (HSV) keratitis with dendritic ulcers, immediate topical antiviral therapy with trifluridine or oral acyclovir is essential to prevent vision-threatening complications.
Critical Diagnostic Distinction
The treatment hinges entirely on distinguishing between two viral etiologies:
Adenoviral Conjunctivitis
- Clinical features: Watery discharge, follicular reaction on inferior tarsal conjunctiva, preauricular lymphadenopathy, often bilateral (sequentially), recent upper respiratory infection or exposure 1
- Natural history: Self-limited, resolves in 5-14 days without treatment 1
- Key point: No specific antiviral is FDA-approved or definitively proven effective
HSV Keratitis
- Clinical features: Vesicular eyelid lesions, dendritic or geographic corneal ulcers (excavated pattern), usually unilateral, may have preauricular node 1
- Natural history: Can resolve in 4-7 days but high risk of severe complications including corneal scarring, perforation, and blindness 1
- Key point: Requires immediate antiviral treatment
Treatment Algorithm
For Adenoviral Conjunctivitis (No Corneal Dendritic Ulcers)
Primary approach: Supportive care
- Cold compresses
- Artificial tears/lubricants
- Strict hygiene measures to prevent transmission
- Patient education on contagiousness (up to 14 days)
Adjunctive therapies for severe cases:
- Povidone-iodine 1% four times daily shows promise in reducing viral load and symptom duration 2, 3, 4
- Topical corticosteroids (dexamethasone 0.1%) can be added if subepithelial infiltrates or pseudomembranes develop, but only after 7-10 days and with concurrent antiviral coverage to avoid prolonging viral shedding 2, 4
- The combination of povidone-iodine 1% + ganciclovir 0.15% + dexamethasone 0.1% significantly reduced symptom severity and complications in a 2026 randomized trial 2
Common pitfall: Avoid prescribing topical antibiotics—they provide no benefit for viral conjunctivitis and contribute to antibiotic resistance 5
For HSV Keratitis (Dendritic/Geographic Ulcers Present)
Immediate antiviral therapy is mandatory:
First-line options (choose one):
- Topical trifluridine 1%: 9 times daily initially, then 5 times daily after re-epithelialization 6, 7
- Topical ganciclovir 0.15% gel: 5 times daily 6
- Oral acyclovir: 400 mg five times daily for 7-10 days 6, 7
Evidence hierarchy: Trifluridine and acyclovir have the strongest evidence base (RR 1.30 and 1.23 vs idoxuridine respectively) 6. Ganciclovir appears at least as effective as acyclovir 6. Oral acyclovir is as effective as topical antivirals and may improve compliance 6.
Adjunctive debridement: Gentle epithelial debridement of infected epithelium may expedite healing but evidence is inconsistent 6
Critical warning: If stromal involvement develops (stromal keratitis with inflammation), add topical corticosteroids only with concurrent prophylactic antiviral coverage to prevent epithelial disease reactivation 7
When to Refer Urgently
- Any corneal involvement (dendritic ulcer, infiltrate, opacity)
- Severe pain or photophobia
- Vision loss
- Immunocompromised patients
- Neonates (risk of HSV or gonococcal infection requiring systemic therapy)
- Pseudomembrane formation in adenoviral cases
- No improvement after 7-10 days
Key Complications to Monitor
Adenoviral: Subepithelial infiltrates (can persist months), pseudomembranes, conjunctival scarring, dry eye 1
HSV: Corneal scarring, perforation, stromal keratitis, uveitis, secondary glaucoma—all vision-threatening 1
Prevention Counseling
- Hand hygiene is paramount
- Avoid touching eyes
- No sharing of towels, pillows, eye drops
- Replace eye cosmetics
- Stay home from work/school during acute phase (adenoviral: up to 14 days)
- For recurrent HSV: Consider long-term oral acyclovir suppression (400 mg twice daily) to reduce recurrence rates 7